The Effect of a Low Glycemic Index Diet on Blood Sugar Control in Pregnant Women at Risk for Gestational Diabetes

Sponsor
University of Toronto (Other)
Overall Status
Completed
CT.gov ID
NCT01105455
Collaborator
(none)
103
1
2
21
4.9

Study Details

Study Description

Brief Summary

Gestational diabetes mellitus (GDM) is a condition in which high blood sugar levels occur during pregnancy. GDM increases the risk of medical complications during pregnancy which may harm the mother and her baby. Since treating GDM to reduce blood sugar reduces the risk of harm, all pregnant women are screened for GDM using a glucose challenge test (GCT). We think that a diet containing low glycemic index foods could help keep blood sugar levels normal during pregnancy and therefore prevent GDM. Thus, the purpose of this study is to see if a diet containing low glycemic index foods will reduced blood sugar after the GCT and reduce the prevalence of GDM in women at high risk for the development of GDM.

Condition or Disease Intervention/Treatment Phase
  • Other: Nutrition education
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
103 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
The Effect of a Low Glycemic Index Diet on Blood Sugar Control in Pregnant Women at Risk for Gestational Diabetes
Study Start Date :
Mar 1, 2010
Actual Primary Completion Date :
Jun 1, 2011
Actual Study Completion Date :
Dec 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: High fiber

High fiber carbohydrate foods with a high / medium glycemic index. Whole wheat bread and/or brown rice are provided to subjects if they wish. Subjects are provided with a list of other recommended carbohydrate foods.

Other: Nutrition education
Group nutrition classes supplemented by handouts and provision of key study foods.

Active Comparator: Low GI

Carbohydrate foods with a low glycemic index. Low GI rice and whole grain bread provided to subjects if they wish. Subjects are provided with a list of recommended foods.

Other: Nutrition education
Group nutrition classes supplemented by handouts and provision of key study foods.

Outcome Measures

Primary Outcome Measures

  1. Serum glucose concentration 1hr after glucose challenge test [26 weeks gestation]

Secondary Outcome Measures

  1. GCT outcome [26 weeks gestation]

    ie. normal, borderline, abnormal

  2. GDM outcome [26 weeks gestation]

    Presence or absence of gestational diabetes

  3. Maternal weight [At EACH of the following times: 12, 16, 20, 24, 28, 32, 36 and 40 weeks gestation]

  4. Mode of delivery [At time of birth of baby]

    Normal or cesarean section

  5. Presence of birth trauma [At time of birth of baby]

  6. Weight of baby [At time of birth of baby]

  7. Presence of macrosomia [At time of birth of baby]

  8. presence of large for gestational age baby [At time of birth of baby]

  9. Presence of small for gestational age baby [At time of birth of baby]

  10. food frequency questionnaire [at 12 weeks and 26 weeks gestation]

  11. Acceptability of study foods [26 weeks gestation]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Attending Mt. Sinai Maternal Fetal Medicine Unit

  • Any ONE of: body mass index >=25 kg/m^2

  • OR age >=35 years

  • OR high risk ethnicity (Asian, South Asian, Hispanic, African, Aboriginal)

Exclusion Criteria:
  • Have pre-existing diabetes (type 1 or type 2) before becoming pregnant

  • Acute or chronic illness which may affect carbohydrate metabolism

  • Language/literacy barriers which cannot be overcome via available resources

  • 16 weeks gestation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mt Sinai Hospital Toronto Ontario Canada M5G 1X5

Sponsors and Collaborators

  • University of Toronto

Investigators

  • Principal Investigator: Thomas MS Wolever, BM, BCh, PhD, University of Toronto

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Thomas Wolever, Professor, University of Toronto
ClinicalTrials.gov Identifier:
NCT01105455
Other Study ID Numbers:
  • MSH REB 09-0263-E
First Posted:
Apr 16, 2010
Last Update Posted:
Mar 12, 2013
Last Verified:
Mar 1, 2013
Keywords provided by Thomas Wolever, Professor, University of Toronto
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 12, 2013